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The pleckstrin homology (PH) domain has been pos-
tulated to serve as an anchor for enzymes that operate
at a lipid/water interface. To understand further the
relationship between the PH domain and enzyme activ-
ity, a phospholipase C (PLC) d1/PH domain enhance-
ment-of-activity mutant was generated. A lysine residue
was substituted for glutamic acid in the PH domain of
PLC d1 at position 54 (E54K). Purified native and mutant
enzymes were characterized using a phosphatidylinosi-
tol 4,5-bisphosphate (PI(4,5)P2)/dodecyl maltoside mixed
micelle assay and kinetics measured according to the
dual phospholipid model of Dennis and co-workers
(Hendrickson, H. S., and Dennis, E. A. (1984) J. Biol.
Chem. 259, 5734–5739; Carmen, G. M., Deems, R. A., and
Dennis, E. A. (1995) J. Biol. Chem. 270, 18711–18714). Our
results show that both PLC d1 and E54K bind phosphati-
dylinositol bisphosphate cooperatively (Hill coeffi-
cients, n 5 2.2 6 0.2 and 2.0 6 0.1, respectively). However,
E54K shows a dramatically increased rate of (PI(4,5)P2)-
stimulated PI(4,5)P2 hydrolysis (interfacial Vmax for
PLC d1 5 4.9 6 0.3 mmol/min/mg and for E54K 5 31 6 3
mmol/min/mg) as well as PI hydrolysis (Vmax for PLC d1 5
27 6 3.4 nmol/min/mg and for E54K 5 95 6 12 nmol/min/
mg). In the absence of PI(4,5)P2 both native and mutant
enzyme hydrolyze PI at similar rates. E54K also has a
higher affinity for micellar substrate (equilibrium dis-
sociation constant, Ks 5 85 6 36 mM for E54K and 210 6 48
mM for PLC d1). Centrifugation binding assays using
large unilamelar phospholipid vesicles confirm that
E54K binds PI(4,5)P2 with higher affinity than native
enzyme. E54K is more active even though the interfacial
Michaelis constant (Km) for E54K (0.034 6 0.01 mol frac-
tion PI(4,5)P2) is higher than the Km for native enzyme
(0.012 6 0.002 mol fraction PI(4,5)P2). D-Inositol trisphos-
phate is less potent at inhibiting E54K PI(4,5)P2 hydrol-
ysis compared with native enzyme. These results dem-
onstrate that a single amino acid substitution in the PH
domain of PLC d1 can dramatically enhance enzyme
activity. Additionally, the marked increase in Vmax for
E54K argues for a direct role of PH domains in regulat-
ing catalysis by allosteric modulation of enzyme
structure.
In many cell types, ligand binding to integral membrane
receptors leads to an increase in the intracellular second mes-
sengers, inositol 1,4,5-trisphosphate (IP3)
1 and diacylglycerol.
This increase results largely from activation of a family of
phosphoinositide-specific phospholipase C (PLC) enzymes that
hydrolyze polyphosphoinositides such as phosphatidylinositol
4,5-bisphosphate (PI(4,5)P2) (3). IP3 releases intracellular Ca
21
from the endoplasmic reticulum via interaction with a specific
receptor located on the surface of the endoplasmic reticulum (3,
4). Diacylglycerol, as well as increased intracellular Ca21, ac-
tivates protein kinase C (PKC) (5). Recent studies suggest that
PLC d1 can be stimulated both by a p122-Rho-GTPase-activat-
ing protein (6) and also by Gh (transglutaminase II) (7). Recent
genetic studies in spontaneously hypertensive rats suggest
that activity of this effector enzyme plays an important role in
the control of blood pressure (5, 8), and light and electron
microscopic studies of PLC d in neurofibrillary tangles suggest
a role in Alzheimer’s disease (9).
PLC d1 hydrolyzes substrate at a lipid/water interface. Ki-
netic analyses developed by Dennis and co-workers (1, 2) are
used to describe this type of enzymatic activity. According to
this dual phospholipid binding model, a soluble enzyme must
first associate with lipid (either specifically or nonspecifically)
to anchor the enzyme to the lipid/water interface. Enzyme
bound to the interface can then subsequently bind its substrate
(within the interface) at the catalytic site where substrate
hydrolysis occurs. For enzymes operating in the “scooting” or
processive mode, multiple catalytic cycles can occur before the
enzyme detaches from the interface (10, 11). The pleckstrin
homology (PH) domain of PLC d1 lies within the NH2-terminal
region of the enzyme. Both this NH2-terminal region (12, 13)
and the PH domain specifically (14) bind to PI(4,5)P2 with high
affinity. Further, this binding is important for processive ca-
talysis to occur (13, 14).
This study seeks to determine the mechanisms of PH do-
main-mediated activation of PLC d1. A mutant PLC d1 (E54K)
was constructed to generate a PH domain enhancement-of-
function mutant. This single amino acid substitution at posi-
tion 54 of PLC d1 dramatically increases the activity of this
enzyme. Using kinetic analyses we show that changes in both
the equilibrium binding constant (Ks) and Vmax contribute to
the increased rate of processive hydrolysis, whereas the inter-
facial binding constant (Km) does not contribute. The position of
this substitution within the PH domain of PLC d1 uniquely
demonstrates the functional importance of this domain. Fur-
ther, the increase in Vmax for E54K suggests a new role for PH
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domains as allosteric regulatory sites. We show that this PH
domain-mediated change in Ks and Vmax is a mechanism for
PLC d1 activation and propose that this may be a general
mechanism for mutant enzymes in which overactivation leads
to human disease.
EXPERIMENTAL PROCEDURES
Materials—Phosphatidylinositol (PI) and phosphatidylethanolamine
(PE) were from Avanti Polar Lipids. Radiolabeled phospholipids were
purchased from DuPont NEN. PI(4,5)P2 was from Calbiochem. PLC d1
monoclonal antibodies were a gift from Dr. Steven Roffler, Academia
Sinica, Taiwan. All other reagents were purchased from Sigma and
were of the highest grade possible.
Mutagenesis of Human PLC d1—Replacement of the single glutamic
acid residue at position number 54 with lysine in human PLC d1 (E54K)
was performed using the polymerase chain reaction described previ-
ously using the bacterial expression plasmid pRSETAplc (15). The
mutant, E54K, was subsequently confirmed by DNA sequence analysis.
Expression and Purification of PLC d1—BL21(DE3) Escherichia coli
(Novagen) were transformed with mutant as well as with wild-type PLC
d1 pRSETA constructs. At appropriate times, the culture was induced
with 10 mM isopropyl-1-thio-b-D-galactopyranoside at 18 °C for about
8 h. The cells were collected by centrifugation and frozen at 220 °C. The
remaining purification protocol was performed according to Cheng et al.
(15) Briefly, cell pellets were ground to a paste in liquid nitrogen using
a mortar and pestle. All subsequent steps were performed at 4 °C using
prechilled buffers. The resulting powder was resuspended in 50 ml of
sonication buffer (50 mM sodium phosphate, pH 8.0, 0.1 M KCl, 1 mM
EGTA, 1 mM EDTA, and 0.1% Tween-20), and sonicated. This suspen-
sion was centrifuged at 17,000 rpm at 4 °C for 45 min. The supernatant
was applied to 5 ml of Ni21-nitrilotriacetic acid-agarose (Qiagen) in
batch mode. The resin was washed 5 times with 250 ml of equilibration
buffer and then five more times with 250 ml of equilibration buffer plus
15 mM imidazole. PLC was eluted with equilibration buffer plus 100 mM
imidazole. Active fractions were identified using a PI hydrolysis assay
and immunoblot. Active fractions were concentrated with Millipore
30,000 NMWL filters and then dialyzed against 1 liter of sonication
buffer plus 10 mM phenylmethylsulfonyl fluoride (added fresh) and 1 mM
dithiothreitol using Pierce dialysis cassettes. For purification to homo-
geneity, samples were applied to 0.5 ml of heparin-Sepharose (Pharma-
cia Biotech Inc.) equilibrated with sonication buffer. Columns were
washed and eluted using a 150 ml of linear salt gradient from 0.1 to 0.5
M KCl in sonication buffer. Active fractions were identified using a PI
hydrolysis assay and Coomassie gel staining.
Assay of PLC d1 Activity—Measurement of PLC d1 catalytic activity
was performed according to the method of Cifuentes et al. (13). Briefly,
PI(4,5)P2 and
3[H]PI(4,5)P2 (4.6 Ci/mmol) or PI and
3[H]PI (11.0 Ci/
mmol) in chloroform/methanol (2:1) were dried in Argon using an N-
EVAP AF automatic thin film drier (Organomation). Final concentra-
tions of PI(4,5)P2 were 1–325 mM, and the concentration of
3[H]-
PI(4,5)P2 was 0.033 mM in a final reaction volume of 30 ml. Final
concentrations of PI were 10–150 mM, and 3[H]PI was 0.2 mM. Dried
lipids were solubilized in a solution of dodecyl maltoside (ranging from
at least 200 mM to 10 mM), 100 mM NaCl, and 20 mM HEPES, pH 7.0.
The mixtures were sonicated, and the free Ca21 was buffered using
EGTA (stability constant for calcium/EGTA of 6.8 3 106 M21). Reactions
were initiated by the addition of enzyme (0.888–566 ng) and carried out
in a 30-ml volume containing mixed micelle substrate, enzyme, 10 mM or
1 mM free Ca21, 100 mM NaCl, 5 mM dithiothreitol, 0.1% gelatin, and 20
mM HEPES, pH 7.0, at 30 °C. Reactions were stopped by the addition of
250 ml of 10% trichloroacetic acid and 25 ml of 20% Triton X-100.
Samples were vortexed briefly and kept on ice for 10 min. Precipitates
were sedimented at 10,000 3 g at 4 °C for 1 min. Supernatants (280 ml
each) were extracted with 1 ml of chloroform/methanol (2:1), and the
aqueous phase (535 ml each), containing the 3[H]IP3 or
3[H]IP product,
was transferred to a scintillation vial and counted for 5 min. PLC d1
activity was also determined using PI/deoxycholate mixed micelles.
50–90 ng of enzyme was added to a 50-ml assay buffer containing 300
mM PI, 25,000 cpm 3[H]PI, 0.1% sodium deoxycholate, 50 mM HEPES,
pH 7.0, 100 mM NaCl, 0.5 mg/ml bovine serum albumin, 3 mM Ca21, and
1 mM EGTA. The reaction was terminated by adding 2 volumes of
CHCl3/methanol/concentrated HCl (100:100:0.6 v/v/v) followed by 1 vol-
ume of 1 N HCl containing 5 mM EDTA. After vortexing and centrifu-
gation at 10,000 3 g for 5 min, the aqueous phase was removed and
counted.
Protein-Lipid Vesicle Binding Assay—20 mg of PI(4,5)P2 and 400 mg
of PE were mixed and dried down to a thin film under N2. PE at 400
mg/ml (520 mM) had previously shown no detectable protein binding.
Lipid mixtures were lyophilized for .4 h and stored at 280 °C. Before
use, 1 ml of 180 mM sucrose was added to the lipid mixtures and bubbled
with N2 for 5 min. One ml of 2 3 binding buffer (100 mM HEPES, pH 7,
200 mM KCl, 10 mM EGTA, 10 mM EDTA) was added. The lipid mixture
was centrifuged for 30 min at 2,000 3 g at 4 °C. The pellet was redis-
solved in 1 ml of 50 mM HEPES, 100 mM KCl, 5 mM EGTA, 5 mM EDTA,
and 200 mg/ml bovine serum albumin. This 1 3 PI(4,5)P2/PE lipid
vesicle solution was serially diluted into solution concentrations of
0.07–18 mM PI(4,5)P2 and 2.0–260 mM PE (constant mol fractions).
Enzyme was added to 190 ml of the PI(4,5)P2/PE mixture and allowed to
incubate at room temperature for 10 min. Enzyme/lipid mixtures were
centrifuged at 4 °C, at 400,000 3 g for 40 min. Supernatants were
removed, and the pellet was redissolved in sodium dodecyl sulfate-
protein buffer and run in a 15% acrylamide gel. The proteins were then
immunoblotted.
Analysis of Kinetic Data—The kinetics for the native and mutant
enzyme were fit to the dual phospholipid binding model originally used
to describe the kinetics of phospholipase A2 (1, 2) (Reaction 1).
E 1 S-|0
k1
k21
ES 1 S-|0
k2
k22
ESSO
k3
ES 1 P
REACTION 1
According to this model, enzyme first associates (via interaction be-
tween a noncatalytic site and lipid moiety) with the lipid/detergent
mixed micelle to form an enzyme-mixed micelle complex. This interfa-
cial binding is a function of the bulk lipid concentration in the mixed
micelle. Thus, to determine the equilibrium dissociation constant for
interfacial binding (denoted here as Ks), we measured substrate hydrol-
ysis as a function of bulk substrate concentration while keeping the mol
fraction of substrate constant (case I). Once the enzyme-mixed micelle
complex forms substrate hydrolysis can then proceed at the catalytic
site. In contrast to interfacial binding, interfacial catalysis is not de-
pendent on bulk concentration of substrate but rather is dependent on
the mol fraction of substrate in the lipid/mixed micelle. Therefore, to
assay substrate binding to the catalytic site as well as the maximum
rate of interfacial catalysis, both the interfacial Michaelis constant
(denoted here as Km) and interfacial Vmax were determined by meas-
uring substrate hydrolysis with increasing mol fractions of substrate
while keeping the bulk concentration of substrate constant (case II).
Covarying bulk lipid concentration and mol fraction yielded a sigmoidal
rate versus [substrate] curve indicative of cooperativity (case III).
Data from all cases were fit to the Hill equation (16) (Equation 1)
using the program PRISM (Graphpad).
n 5
Vmax z @S#n
K9 1 @S#n
(Eq. 1)
n 5 rate, Vmax 5 maximum rate, [S] 5 initial substrate concentration,
n 5 Hill coefficient, and K9 is a complex association factor.
Determination of Ks—For case I data, Equation 1 reduces to the
Henri Michaelis-Menten equation or simple rectangular hyperbola with
slope, n, equal to 1. Data were fit to Equation 2 from which values of the
equilibrium dissociation constant (Ks) were obtained.
n 5
Vmax z @S#
Ks 1 @S#
(Eq. 2)
Determination of Km and Vmax—For case II data, a sigmoidal curve fit
better than a rectangular hyperbola with slope equal to 1. Therefore,
data were fit to Equation 3 using the Hill coefficient derived from case
III data (16) and Km as well as Vmax determined.
n 5
Vmax z @X#case III
n
Km 1 @X#case III
n (Eq. 3)
Km is the interfacial Michaelis-Menten constant, Vmax is the interfacial
Vmax at a constant PI(4,5)P2 concentration of 100 mM, X is the mol
fraction of substrate, and ncase III is the Hill coefficient derived from case
III. Data from case III were fit to a sigmoidal curve according to
Equation 1 where K9 in this case is defined by the intrinsic association
factors of different lipid binding sites with the Hill coefficient, n, equal
to the total number of binding sites.
RESULTS
Mutagenesis of PLC d1—The cDNA for human PLC d1 was
mutated to substitute a lysine for glutamic acid at residue
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position 54 (Fig. 1A). This residue lies in the b3/b4 loop of the
PH domain of PLC d1 (17). The backbone carbonyl of Glu-54
interacts with the 5 position of the inositol headgroup via a
water-mediated hydrogen bond (17). We hypothesized that ly-
sine substitution at this position would enhance affinity for
phosphoinositides. This might occur because lysine is a fully
charged species at physiological pH, and this ionic interaction
would lead not only to displacement of a water molecule but
also to enhanced bonding of the positively charged lysine with
the negatively charged oxygen at the 5 phosphate of the inositol
head group (Fig. 1B). Purified proteins were assayed for their
ability to hydrolyze PI in a sodium deoxycholate/PI mixed mi-
celle assay. Both native and mutant enzyme showed a very
similar specific activity toward hydrolysis of PI, 0.95 mmol/
min/mg for PLC d1 and 1.2 mmol/min/mg for E54K, ensuring
that the substitution E54K has not globally affected enzyme
structure or activity.
Mutant PLC d1 E54K Has Increased Hydrolytic Activity—
PI(4,5)P2 hydrolysis was assayed according to case III condi-
tions as described under “Experimental Procedures.” Substrate
hydrolysis was measured simultaneously varying the bulk con-
centration and mol fraction of PI(4,5)P2. This was accomplished
using multiple assays where the concentration of dodecyl mal-
toside was kept constant at 200 mM (to ensure that [detergent]
was greater than the critical micellar concentration) and the
PI(4,5)P2 concentration increased from 1 to 75 mM. With dode-
cyl maltoside as diluent, rates of substrate hydrolysis are linear
over 4 min, with r2 values ranging from 0.95 to 0.99. When solid
lines were fit to both sets of data using Equation 1 from “Ex-
perimental Procedures,” the Hill coefficient of PLC d1 was
calculated to be 2.2 6 0.2 and for E54K was calculated to be
2.0 6 0.1 (Table I). Further, Fig. 2 shows that E54K has a
dramatically enhanced rate of catalysis. Thus, the single sub-
stitution in the PH domain of this PLC d1 dramatically en-
hances its rate of hydrolysis but does not change the inherent
cooperativity in enzyme activity.
Determination of Km—The effect of the mutation E54K on
secondary binding within the interface (Km) was determined by
assaying native and mutant activity according to case II con-
ditions as described under “Experimental Procedures.” Multi-
ple measurements of enzyme activity were made at a constant
bulk concentration of PI(4,5)P2 (100 mM was chosen as this
value is similar to the calculated Ks for E54K (Table I)) and
varying mol fractions of substrate (0.01–0.25 mol fraction
PI(4,5)P2) using dodecyl maltoside as diluent (Fig. 3). The mol
fraction of PI(4,5)P2 was not increased above 0.25 because the
kinetics of PI(4,5)P2 hydrolysis deviated from linearity above
0.25 (data not shown) as has been observed by other investiga-
tors (16). Solid lines were fit to the data using Equation 3
FIG. 1. Schematic representation of PLC d1 and proposed in-
teraction between K54 and IP3. Panel A, PLC d1 is schematically
represented showing locations of X, Y, and PH domains. The glutamic
acid residue at position 54 was replaced by a basic lysine residue.
Position 54 is within the PH domain (amino acids 16–124). Panel B, the
diagram of the PH domain/D-IP3 binding site is based on the crystal
structure of PLC d1 PH domain complexed with IP3 (17). The substi-
tuted lysine residue at position 54 is proposed to interact with an
oxygen at the 5 phosphate position of the substrate inositol head group.
TABLE I
Comparison of PLC d1 and E54K kinetic constants derived from
activity assays according to case I, II, and III
PLC d1 and E54K catalytic hydrolysis of PI(4,5)P2/dodecyl maltoside
mixed micelles was carried out in 10 mM Ca21 (buffered with EGTA),
100 mM NaCl, 5 mM dithiothreitol, 0.1% gelatin, and 20 mM HEPES, pH
7.0. Kinetic constants were according to case I, II, or III as described
under “Experimental Procedures.” The Hill coefficients (n) were calcu-
lated by fitting case III data to Equation 1. Both the interfacial Michae-
lis-Menten constant (Km) as well as the interfacial Vmax were calculated
by fitting case II data to Equation 3. The equilibrium dissociation
constants (Ks) were calculated by fitting case I data to Equation 2. Data
are means 6 S.E.
Hill coefficient n
case III
Interfacial Km
case II
Ks
case I
Vmax
case II
mM mmol/min/mg
PLCd1 2.2 6 0.2 0.012 6 0.002 210 6 48 4.9 6 0.3
E54K 2.0 6 0.1 0.034 6 0.01 85 6 36 31 6 3
FIG. 2. PLC d1 and E54K show the same degree of catalytic
cooperativity, but E54K has a higher initial rate of PI(4,5)P2
hydrolysis. Initial rates of substrate hydrolysis are shown for native
(f) and mutant () enzyme as a function of both bulk PI(4,5)P2 concen-
tration and mol fraction of substrate (case III). Activity toward
PI(4,5)P2/dodecyl maltoside mixed micelles was assayed according to
case III conditions as stated under “Experimental Procedures” with the
concentration of dodecyl maltoside fixed at 200 mM and the concentra-
tion of PI(4,5)P2 varied. Solid lines were fit to raw data using Equation
1 from which Hill coefficients were obtained (Table I). Error bars rep-
resent the S.E. (n 5 2) and are shown when larger than the symbol.
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(“Experimental Procedures”) which describes case II activity.
The data fit a sigmoidal curve better than a hyperbolic one.
This result has also been noted when measuring case II activity
of PLC b (16) and phospholipase A2 (1). For PLC d1, Km 5
0.012 6 0.002, and for E54K Km 5 0.034 6 0.01 (Table I). Vmax
for PLC d1 was 4.9 6 0.3 mmol/min/mg and 31 6 3 mmol/
min/mg for E54K (Table I).
Determination of Ks—The effect of E54K on initial binding to
the interface was determined by assaying enzyme activity ac-
cording to case I conditions as described under “Experimental
Procedures.” Multiple assays were performed with varying
bulk concentrations of PI(4,5)P2 (10–325 mM) yet keeping the
mol fraction of PI(4,5)P2 constant. This was achieved by in-
creasing the bulk concentration of PI(4,5)P2 (adding more lipid)
while simultaneously increasing the concentration of dodecyl
maltoside thus ensuring that the PI(4,5)P2 mol fraction was
kept constant at 0.04. This value was chosen as it approximates
the Km for E54K. Solid lines were fit to the data using Equation
2 which simply describes a rectangular hyperbola with slope
equal to 1 from which values of Ks were determined. E54K was
much more active than native enzyme even at relatively low
substrate concentrations (Fig. 4). The Ks for PLC d1 was cal-
culated to be 210 6 48 mM, whereas the Ks for E54K was only
85 6 36 mM (Table I). These values were within the range of
constants determined previously for PLC b (16), PLC g (18, 19),
and PLC d1 (13, 14).
In addition to the kinetic analysis, a thermodynamic equi-
librium centrifugation binding assay was done to examine fur-
ther initial binding to substrate. This assay was not used
quantitatively since the kinetic data were more reliable, and
the equilibrium association constant Ka (or
1
Ks
) has not always
provided good agreement with affinity constants determined
kinetically (13, 16). However, it was used qualitatively as an-
other independent measure of the relative affinities of native
and mutant enzyme for PI(4,5)P2/PE LUVs. E.54K was associ-
ated with LUVs at much lower concentrations of PI(4,5)P2 than
is the case for PLC d1 (Fig. 5). At about 1.1 mM PI(4,5)P2 PLC
d1 was no longer associated with LUVs, suggesting that it no
longer bound to PI(4,5)P2 at this concentration. However, even
at concentrations as low as 0.07 mm PI(4,5)P2 E54K still asso-
ciated with the LUVs. Neither enzyme bound to PE LUVs alone
over the range of PE concentrations used in this assay (data not
shown).
PI(4,5)P2 Enhances the Rate of PI Hydrolysis for Both PLC d1
and E54K—PI hydrolysis was assayed according to case III
conditions described under “Experimental Procedures.” The
concentration of dodecyl maltoside was kept constant at 200
mM, and the PI concentration increased from 10 to 150 mM.
When solid lines were fit to both sets of data using Equation 1
from “Experimental Procedures,” the Hill coefficient of PLC d1
was calculated to be 1.9 6 0.2 and for E54K was calculated to
be 2.0 6 0.4 (Fig. 6). Fig. 6 shows that both PLC d1 and E54K
have similar rates of catalysis for PI in the absence of PI(4,5)P2
(Vmax for PLC d1 5 15 6 2 nmol/min/mg and Vmax for E54K 5
18 6 2 nmol/min/mg). Assays were also performed in the pres-
ence of 50 mM PI(4,5)P2. Hydrolysis of substrate under these
conditions was still cooperative with Hill coefficients of 1.5 6
0.3 for PLC d1 and 1.6 6 0.6 for E54K. In the presence of
PI(4,5)P2 (Fig. 6), PLC d1 activity was enhanced 2-fold (Vmax 5
27 6 3 nmol/min/mg), but E54K activity was enhanced more
than 5-fold (Vmax 5 95 6 10 nmol/min/mg).
D-IP3 Inhibits PLC d1 and E54K—D-IP3 inhibited PI(4,5)P2
hydrolysis for both native and mutant enzyme. Dodecyl malto-
side/PI(4,5)P2 mixed micelles were assayed according to “Ex-
perimental Procedures” with constant PI(4,5)P2 (1 mM) and
dodecyl maltoside (200 mM) concentrations. D-IP3 (0 to 25 mM)
was added to each assay prior to addition of enzyme. Both
enzymes were inhibited by D-IP3 in a dose-dependent manner
FIG. 3. PLC d1 and E54K have similar Km values though E54K
has a higher Vmax for PI(4,5)P2 hydrolysis. Initial rates of substrate
hydrolysis are shown for native (f) and mutant () enzyme as a func-
tion of PI(4,5)P2 surface concentration or PI(4,5)P2 mol fraction (case
II). Activity toward PI(4,5)P2/dodecyl maltoside mixed micelles was
assayed for case II conditions according to “Experimental Procedures.”
The dodecyl maltoside concentration was varied to vary the PI(4,5)P2
mol fraction, and the PI(4,5)P2 concentration was fixed at 100 mM. Solid
lines were fit to raw data using Equation 3 from which values of Km and
Vmax were obtained (Table I). Error bars represent the S.E. (n 5 2) and
are shown when larger than the symbol.
FIG. 4. E54K has both a lower Ks value than PLC d1 as well as
a higher initial rate of PI(4,5)P2 hydrolysis. Initial rates of sub-
strate hydrolysis are shown for native (f) and mutant () enzyme as a
function of bulk PI(4,5)P2 concentration (case I). Activity toward
PI(4,5)P2/dodecyl maltoside mixed micelles was assayed for case I con-
ditions according to “Experimental Procedures.” PI(4,5)P2 concentra-
tion and dodecyl maltoside were covaried while keeping the PI(4,5)P2
mol fraction constant at 0.04. Solid lines were fit to raw data using
Equation 2 from which values of Ks were obtained (Table I). Error bars
represent the S.E. (n 5 2) and are shown when larger than the symbol.
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(Fig. 7). The shift in the dose-response curve to the right for
E54K was consistent with data demonstrating higher interfa-
cial binding but might also suggest that this mutant bound
D-IP3 less well than native enzyme.
DISCUSSION
The dual phospholipid model (1, 2) is used extensively to
characterize the activity of a number of enzymes that operate
processively at a lipid/water interface (1, 16, 19). According to
this model, enzymes must first associate with an interface that
contains substrate to form an enzyme-interface complex (Reac-
tion 1). Enzyme attachment to the interface has been shown to
occur via protein/lipid interactions (13, 14, 16, 20) but could
also occur via protein/protein interactions. Interface binding
can be due to specific or nonspecific recognition of anchoring
ligand, which may or may not be a true substrate for the
enzyme. The model necessitates two distinct binding sites: an
anchoring and catalytic site. For PLC d1, these two sites exist
in a single molecule (13–15). Interface binding is mediated
through an NH2-terminal PH domain (13, 14). This domain has
been shown in PLC d1 to bind polyphosphoinositides with high
affinity and specificity (13, 14, 17, 21). Secondary binding of
substrate occurs at the catalytic domain with a lower affinity
(100 mM) (13, 14, 17, 21, 22).
The tertiary structure of the PLC d1 PH domain complexed
to IP3 was recently solved by x-ray crystallography at a reso-
lution of 1.9 Å (17). IP3 binds to the PH domain of PLC d1 with
very high affinity (Kd 5 210 nM) (17). Other investigators
functionally demonstrate a high affinity interaction among IP3,
PLC d1 (23), and its PH domain (21). Several residues in the
PLC d1 PH domain interact directly with the phosphates of the
inositol headgroup. These include basic residues Lys-30, Lys-
32, and Lys-57 as well as a Van der Waals interaction between
Trp-36 and the inositol ring (17). In fact, our laboratory has
shown the functional importance of many of these residues.
Substitution of Lys-30, Lys-32, and Trp-36 with glycine greatly
attenuates substrate binding and hydrolysis (14). The glutamic
acid residue at position 54 interacts with the 5 phosphate
through a water-mediated hydrogen bond (17). The lysine sub-
stitution at this position (Fig. 1A) changes the charge state
from 21 to 11, providing a positively charged species that may
enhance binding to a negatively charged phosphate of the ino-
sitol head group for IP3 as well as other phosphoinositides (Fig.
1B) (17). We propose that the tighter binding of PI(4,5)P2 to
E54K is because of stronger direct ionic interactions with the
lysine and elimination of potentially unfavorable interactions
between the negatively charged native glutamic acid and
PI(4,5)P2.
PI hydrolysis in PI/sodium deoxycholate mixed micelles was
used to assess PLC d1 activity during and following purifica-
tion. Both native (0.95 mmol/min/mg) and mutant (1.2 mmol/
min/mg) enzyme have a similar specific activity toward hydrol-
ysis of PI in PI/deoxycholate micelles, indicating that the
tertiary structure of E54K has not been adversely affected by
the amino acid substitution. A PI(4,5)P2/dodecyl maltoside
mixed micelle assay was used to characterize the kinetics of
enzyme activity. This system has been used to characterize
PLC b1, PLC b2, turkey erythrocyte PLC (16), and PLC d1 (13).
The main advantage in using dodecyl maltoside is that it is an
inherently neutral diluent of PI(4,5)P2. Increasing mol frac-
tions of detergent are not inhibitory toward PLC activity (16).
As reported by other groups (13, 14, 16), we find that so-called
neutral diluents such as phosphatidylcholine (PC) and phos-
phatidylserine (PS) can affect PLC activity with PC being in-
hibitory and PS being stimulatory (data not shown). This
makes these lipids less desirable as diluents of substrate since
FIG. 5. E54K has a higher affinity for PI(4,5)P2 in LUVs than
native PLC d1. Native and mutant enzyme were incubated with su-
crose-loaded LUVs (20:1 PE/PI(4,5)P2) with a range of PI(4,5)P2 con-
centrations (0.07–18 mM). This was followed by ultracentrifugation as
described under “Experimental Procedures.” PLC d1 and E54K protein
remaining in the pellet were quantitated using sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and Western blot and were com-
pared with controls. PLC d1 bound to LUVs with PI(4,5)P2 concentra-
tions as low as 1.1 mM. E54K also bound to LUVs but bound at PI(4,5)P2
concentrations below 1.1 mM even down to 0.07 mM, suggesting that
E54K has a much higher affinity for PI(4,5)P2 in sucrose-loaded LUVs.
The experiment shown is representative of multiple experiments that
gave relatively similar results within each assay (E54K bound better
than PLC d1), but variability among assays precludes determination of
rigorous binding constants.
FIG. 6. PI(4,5)P2 enhances PI hydrolysis for PLC d1 and E54K,
but E54K is enhanced more than PLC d1. Panel A, native enzyme
initial rates of substrate hydrolysis are shown as a function of both bulk
PI concentration and mol fraction of substrate (case III). Activity to-
ward PI/dodecyl maltoside mixed micelles was assayed according to
case III conditions as stated under “Experimental Procedures” with the
dodecyl maltoside concentration fixed at 200 mM, calcium concentration
fixed at 1 mM, and PI concentration varied. Solid symbols indicate
activity in the absence of any PI(4,5)P2. Open symbols indicate activity
in the presence of 50 mM PI(4,5)P2. Panel B, mutant enzyme was
assayed equivalently. Solid lines were fit to raw data using Equation 1
from which Vmax and Hill coefficients were obtained. Error bars repre-
sent the S.E. (n 5 2) and are shown when larger than the symbol.
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they are not true neutral diluents, and observed effects on
PI(4,5)P2 hydrolysis might be attributed to various complex
diluent effects instead of substrate effects.
In agreement with several investigators (13, 14, 24), PLC d1
hydrolysis of PI(4,5)P2 and PI is processive and cooperative.
The Hill coefficients for native and mutant enzyme for hydrol-
ysis of substrates PI(4,5)P2 and PI range from 1.5 to 2.2 (Table
I). This suggests that at least 2 mol of substrate bind per mol of
both PLC d1 and E54K. Further, the similarity among Hill
coefficients for native and mutant enzyme for both PI(4,5)P2
and PI substrate suggests that the E54K mutation has not
affected the inherent processivity of PLC d1. A likely model for
this processivity is that one molecule of substrate must bind to
the catalytic site with the second molecule of PI(4,5)P2 binding
to the PH domain( 13, 14, 16, 25) which serves as an anchor or
site of allosteric modulation. Clearly, the PH domain is not
solely responsible for processivity even among PLC enzymes.
The PI-PLC from Bacillus cereus also hydrolyzes PI proces-
sively even though this enzyme contains no PH domain (26). In
addition, human PLC d1 that has 70 amino acids deleted from
the PH domain can hydrolyze PI processively (14).
To understand fully the mechanisms of activation of enzymes
that act at a lipid/water interface, it is necessary to determine
the contribution of interfacial binding and catalysis in overall
enzyme activation. Hendrickson and Dennis (20) demonstrate
that didecanoyl-PC activation of secretory phospholipase A2
substrate (thio-PE) hydrolysis is dependent on the surface con-
centration of didecanoyl-PC rather than on the bulk concentra-
tion of this activator. Further, they find that didecanoyl-PC
activation of thio-PE substrate results not from an increase in
secondary binding within the interface (no change in Km) but
by increasing the catalytic rate or efficiency of the enzyme (by
increasing the Vmax). Studies with the phospholipase A2 inhib-
itor manoalide also show that interface binding is not crucial
for PC stimulation of PE hydrolysis (27).
Previous studies with PLC enzymes indicate that changes in
Ks, Km, and Vmax mediate enzyme activation. Wahl et al. (19)
find that epidermal growth factor-activated enzyme has a
4-fold lower Km for PI(4,5)P2 hydrolysis as well as a 7.5-fold
lower Ks. This demonstrates that both interfacial binding as
well as secondary substrate binding within the interface medi-
ate the epidermal growth factor stimulation of PLC g1
PI(4,5)P2 hydrolysis. The Vmax values for activated and inacti-
vated enzymes are equivalent, suggesting that activation does
not affect catalytic efficiency. Work from our laboratory (14)
shows that PI(4,5)P2-mediated stimulation of PLC d1 PI hy-
drolysis results from decreases in both Ks and Km, although the
largest magnitude change is in Ks. Again, Vmax values for
activated and unactivated enzymes are equivalent. Jones and
Carpenter (18) report that phosphatidic acid enhances
PI(4,5)P2 hydrolysis not by increasing the affinity of PLC g1 for
substrate micelles but by decreasing the Km of the activated
enzyme 10-fold and increasing the Vmax 4-fold. These data
suggest that phosphatidic acid activation of PLC g1 occurs not
by affecting the affinity of enzyme for initial binding to sub-
strate but by affecting secondary binding within the substrate
interface or by affecting interfacial catalytic efficiency. bg sub-
units of heterotrimeric G-proteins activate the PLC b2 enzyme
(28, 29). Romoser et al. (28) find that at activating concentra-
tions of bg subunits, PLC b2 does not show any increased
affinity for PI(4,5)P2/lipid vesicles (28). Although the authors
do not demonstrate the mechanism of activation, their data
suggest that interfacial binding does not play a role in activa-
tion by bg subunits.
The results reported here demonstrate that catalytic effi-
ciency (Vmax) and interfacial binding (Ks) are the primary de-
terminants of PLC d1 enhanced activity. The PH domain mu-
tant E54K has markedly enhanced catalytic activity (Fig. 3).
Kinetic analyses show that E54K has a much higher Vmax (31
mmol/min/mg) than does PLC d1 (4.9 mmol/min/mg) (Table I).
However, the Km for E54K is actually a bit higher (0.034 mol
fraction PI(4,5)P2) than for PLC d1 (0.012 mol fraction
PI(4,5)P2) (Table I). These data suggest that the affinity for
PI(4,5)P2 binding within the interface at the catalytic site is
unchanged or even lower so that, all things equal, E54K and
native enzyme should have the same rates of substrate hydrol-
ysis, or E54K should hydrolyze substrate less well. Therefore,
increased catalytic efficiency (Vmax) is likely a determining
factor in the observed enhanced activity of E54K.
E54K shows a reduction of approximately 2.5-fold in the Ks
(85.0 mM) compared with native enzyme (211.5 mM) (Fig. 4 and
Table I). These data suggest that the increased activity of E54K
is partially a result of enhanced initial binding to the interface.
A centrifugation binding assay with LUVs confirms the en-
hanced interface binding of E54K. E54K is able to bind to lower
concentrations of PI(4,5)P2 in LUVs than PLC d1. These data
are not examined quantitatively in part because the kinetic
constants are more rigorous, and the equilibrium association
constant Ka (or
1
Ks
) has not always provided good agreement
with affinity constants determined kinetically (13, 16). The
poor agreement between Ks and Ka may be the result of differ-
ent lipid interfaces differentially affecting enzyme vesicle bind-
ing affinity (14, 16). In addition, the assumption of 1:1 stoichi-
ometry between PI(4,5)P2 and enzyme might be violated given
that results for case II data are sigmoidal, indicating cooperat-
ivity of binding within the interface. Among other things this
may indicate the presence of another PI(4,5)P2 binding site
within the interface. Some likely structural candidates might
be the C2 domain (30) or the gelsolin-like PI binding domain
FIG. 7. D-IP3 inhibits both PLC d1 and E54K. Initial rates of substrate
hydrolysis for native (f) and mutant () enzyme were measured in the
absence or presence of varying concentrations of D-IP3. Activity toward
PI(4,5)P2/dodecyl maltoside mixed micelles was assayed using 0.033 mM
[3H]PI(4,5)P2, 1 mM PI(4,5)P2, and 200 mM dodecyl maltoside 6 0–25 mM
D-IP3 as described under “Experimental Procedures.” Both enzymes are
inhibited by low concentrations of D-IP3. PLC d1 is inhibited by as little
as 1 mM D-IP3, and maximum inhibition is observed by 10 mM inhibitor.
In contrast, E54K is also inhibited by D-IP3 but not to the same extent
as native enzyme. Error bars represent the S.E. (n 5 2) and are shown
when larger than the symbol.
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(31), both of which are found in PLC d1.
The E54K mutation has not generated a constitutively active
PLC d1 since rates of PI hydrolysis for native and mutant
enzymes are equivalent in the absence of PI(4,5)P2 (Fig. 6). PI
hydrolysis is cooperative similar to PI(4,5)P2 hydrolysis, sug-
gesting that both substrates serve as PH domain ligands. 50 mM
PI(4,5)P2 enhances the rates of PI hydrolysis for both enzymes,
which shows that PI(4,5)P2 is specifically required for en-
hanced activity (Fig. 6). These results agree with previous data
showing that PI(4,5)P2 increases the rate of PI hydrolysis by
wild-type enzyme in phospholipid vesicles (14). The kinetic
data support a mechanism where PI(4,5)P2 specifically binds to
the PH domain and allosterically modulates the active site of
the enzyme increasing catalytic efficiency. A mechanism of
allosteric modulation of catalysis by phospholipid binding has
also been proposed for PKC (32, 33). PS cooperatively enhances
the activity of PKC in PS/Triton X-100 mixed micelles with a
high degree of specificity (33). Further, PS binding to PKC
enhances proteolysis at a specific site of the enzyme, suggesting
that PS binding induces an allosteric modulation of PKC
structure (34).
Both native and E54K enzyme can be inhibited by low con-
centrations of D-IP3 (Fig. 7). Interestingly, the data show that
D-IP3 is less potent at E54K than native PLC d1 (Fig. 7).
Although the mechanism for this difference is unclear, it might
be because of E54K increased affinity for PI(4,5)P2. These data
are somewhat surprising given that D-IP3 and PI(4,5)P2 have
been shown to have similar high affinities for the PLC d1 PH
domain (21, 35), which suggests that the structural determi-
nants mediating a high affinity interaction between PH domain
and the phosphoinositides are in the polar head group (17). The
mechanisms of this differential inhibition will be explored in
the future.
In summary, we have found that a single amino acid substi-
tution of PLC d1 leads to enzyme activation. The mutation is a
lysine for glutamic acid substitution at position 54 within the
PH domain. The native and mutant enzymes were character-
ized using the dual phospholipid binding model of Hendrickson
and Dennis (1). The data show that both native and mutant
enzymes operate in the same processive mode of hydrolysis,
both binding to 2 mol of PI(4,5)P2/mol of enzyme. The interfa-
cial Vmax for E54K is about 6-fold greater than that for native
PLC d1. The data also show that E54K shows no increase in
substrate binding within the PI(4,5)P2/dodecyl maltoside mi-
celle interface (Km). However, in both kinetic and thermody-
namic assays, E54K has an increased affinity for initial sub-
strate binding. In fact, the Ks for E54K is approximately 2.5-
fold lower than that of native enzyme. PI(4,5)P2 also enhances
PI hydrolysis for PLC d1 by almost 2-fold but more than 5-fold
for E54K. Thus, both increased interfacial binding and in-
creased catalytic efficiency enhance enzyme activity. The PH
domain mediates these effects in PLC d1. It is interesting to
speculate that this same mechanism of activation may operate
for other enzymes as well. The small nonreceptor tyrosine
kinase, Bruton’s tyrosine kinase, also has a PH domain. In fact,
when the conserved mutation E54K is made in this enzyme
(E41K), the result is a 100-fold increase in cell growth in
NIH-3T3 cells and enhanced Bruton’s tyrosine kinase mem-
brane association (36). Although the mechanism for this gain of
function is not clear, recent evidence shows that Bruton’s tyro-
sine kinase PH domain containing the E41K mutation binds to
inositol 1,2,3,4,5,6-hexakisphosphate 2-fold better than native
Bruton’s tyrosine kinase PH domain (37). Given that the PH
domain is the structural determinant mediating PLC d1 mem-
brane translocation (38) and enzyme activation (14), it is pos-
sible that the in vivo transformation and membrane localiza-
tion seen in the mutant Bruton’s tyrosine kinase follow the
mechanism we have proposed for E54K/PLC d1. There is al-
ready ample evidence demonstrating that the PH domain of
various enzymes mediates enzyme translocation to membranes
(14, 36, 38, 39). Our data show the importance of membrane
association and allosteric modulation in mediating enzyme ac-
tivation in vitro.
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